BMD-MSCs

Status
Phase 1
Condition
Other ILD
Intervention Type
Intravenous (IV) Injection
Funder Type
Organization | University

Drug Details

Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)

Study Purpose

Researchers are trying to find out more about the safety of a new treatment, Allogeneic (coming from a healthy donor) Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs) which is still experimental, for Interstitial Lung Disease (ILD) associated with Connective Tissue Disorder (CTD). 

Find a Clinical Trial
footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >